Legal Opinion
Proctor & Gamble Co. v. Teva Pharmaceuticals USA, Inc.
District Court, D. Delaware
Decided February 28, 2008No. Civil Action 04-940-JJFPublishedCited by 3 opinions
1Opinion of the Court
OPINION
JOSEPH J. FARNAN, Jr., District Judge.
INTRODUCTION
This action was filed by The Proctor & Gamble Company (“Proctor & Gamble”) against Teva Pharmaceuticals USA, Inc. (“Teva”), alleging patent infringement. Proctor & Gamble’s original Complaint, filed on August 13, 2004, alleged that Teva’s efforts to market a generic version of risedronate sodium infringed on United States Patent Nos. 5,538,122 (“the 122 Patent”) and 6,096,342. 1 (D.I. 1.) On August 25, 2004, Proctor & Gamble amended its Complaint to limit its infringement allegations to only the 122 Patent. (D.I. 5.)
Proctor & Gamble is…
2Cases cited23 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Stratoflex, Inc. v. Aeroquip CorporationCourt of Appeals for the Federal Circuit · 1983
- Colorado v. New MexicoSupreme Court of the United States · 1984
- Richard C. Price v. Dale R. SymsekCourt of Appeals for the Federal Circuit · 1993
18 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- Procter & Gamble Co. v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2009
- Bristol-Myers Squibb Co. v. Teva Pharmaceuticals USA, Inc.District Court, D. Delaware · 2013
- Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.District Court, S.D. New York · 2012